Zobrazeno 1 - 10
of 20
pro vyhledávání: '"J R Petrie"'
Autor:
George J. Haidukewych, J. R. Petrie
Publikováno v:
The bonejoint journal. (1 Suppl)
Instability is a common indication for early revision after both primary and revision total knee arthroplasty (TKA), accounting for up to 20% in the literature. The number of TKAs performed annually continues to climb exponentially, thus having an ef
Autor:
H M, Colhoun, S J, Livingstone, H C, Looker, A D, Morris, S H, Wild, R S, Lindsay, C, Reed, P T, Donnan, B, Guthrie, G P, Leese, J, McKnight, D W M, Pearson, E, Pearson, J R, Petrie, S, Philip, N, Sattar, F M, Sullivan, P, McKeigue, R, McAlpine
Publikováno v:
Diabetologia
Colhoun, H, Livingstone, S J, Looker, H C, Morris, A D, Wild, S H, Lindsay, R S, Reed, C, Donnan, P T, Guthrie, B, Leese, G P, McKnight, J, Pearson, D W M, Pearson, E, Petrie, J R, Philip, S, Sattar, N & Sullivan, F M & McKeigue, P 2012, ' Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs ', Diabetologia, vol. 55, no. 11, pp. 2929-2937 . https://doi.org/10.1007/s00125-012-2668-0
Colhoun, H, Livingstone, S J, Looker, H C, Morris, A D, Wild, S H, Lindsay, R S, Reed, C, Donnan, P T, Guthrie, B, Leese, G P, McKnight, J, Pearson, D W M, Pearson, E, Petrie, J R, Philip, S, Sattar, N & Sullivan, F M & McKeigue, P 2012, ' Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs ', Diabetologia, vol. 55, no. 11, pp. 2929-2937 . https://doi.org/10.1007/s00125-012-2668-0
AIMS/HYPOTHESIS: Current drug labels for thiazolidinediones (TZDs) warn of increased fractures, predominantly for distal fractures in women. We examined whether exposure to TZDs affects hip fracture in women and men and compared the risk to that foun
Autor:
J. R. Petrie
Publikováno v:
Journal of Clinical Endocrinology & Metabolism. 83:1552-1557
Publikováno v:
Diabetes. 43:1445-1449
Autor:
A F B, Kernohan, N, Sattar, T, Hilditch, S J, Cleland, M, Small, M A, Lumsden, J M C, Connell, J R, Petrie
Publikováno v:
Clinical endocrinology. 66(1)
Low-dose hormone replacement therapy (HRT) has attracted interest for the treatment of postmenopausal symptoms in diabetes because of concerns about increased risk of coronary heart disease (CHD) and stroke with conventional HRT containing conjugated
Publikováno v:
Diabetic medicine : a journal of the British Diabetic Association. 21(3)
To determine whether carotid-radial pulse wave velocity (crPWV), a simple non-invasive measurement of muscular artery structure and function, is increased in offspring of patients with Type 2 diabetes compared with well-matched controls with no famil
Publikováno v:
The Journal of clinical endocrinology and metabolism. 85(5)
Angiotensin-converting enzyme (ACE) inhibitors are increasingly used as first-line therapy for hypertension in type 2 diabetes mellitus and are widely believed to improve insulin sensitivity (M). However, the evidence for the latter effect does not s
Publikováno v:
Clinical science (London, England : 1979). 98(5)
Low-grade chronic inflammation, characterized by elevated plasma concentrations of C-reactive protein (CRP), is associated with an increased risk of atherosclerotic cardiovascular disease. Endothelial cell activation is an early event in atherogenesi
Publikováno v:
Diabetic medicine : a journal of the British Diabetic Association. 15
Death from myocardial infarction was a rare clinical entity at the beginning of this century, but with an ageing population it is poised to become the most common cause of death worldwide. Ample epidemiological evidence confirms the clinical impressi
Publikováno v:
The Journal of clinical endocrinology and metabolism. 83(6)
During systemic hyperinsulinemia in man, skeletal muscle vasodilation has consistently been demonstrated. However, most studies that have examined the vascular effect of local hyperinsulinemia have reported either no effect or only weak vasodilation,